Profusa (PFSA) Return on Invested Capital (2022 - 2025)
Profusa (PFSA) posted quarterly Return on Invested Capital of 0.0% for Q2 2025, up 33.75% quarter-over-quarter from 0.01% in Q1 2025.
Profusa (PFSA) Return on Invested Capital (2022 - 2025) Analysis & Trends
Profusa's Return on Invested Capital history runs 3 years deep, the most recent figure standing at 0.0% for Q2 2025.
- In Q2 2025, Return on Invested Capital changed N/A year-over-year to 0.0%; the TTM figure through Jun 2025 stood at 0.0% (changed N/A YoY), while the FY2022 annual figure was 0.9%, changed N/A from the prior year.
- Return on Invested Capital for Q2 2025 stood at 0.0%, up from 0.01% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.0% in Q2 2025, with the low at 0.42% in Q4 2022.
- The 3-year median for Return on Invested Capital is 0.31% (2023), against an average of 0.23%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 0.01% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 0.01% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 0.01% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 0.00% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 0.01% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 0.00% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 0.04% |
| 10 | Profusa | 92,085.85 | -282,914.15 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | -0.01% |
| Sep 30, 2023 | -0.31% |
| Jun 30, 2023 | -0.34% |
| Mar 31, 2023 | -0.30% |
| Dec 31, 2022 | -0.42% |